17 February 2025
Dr Kerrie Lewis
Ductal carcinoma in situ: Treatment and prognosis
Ouattara, Drissa et al.Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis. Journal of clinical medicine vol. 12,5 2036. 3 Mar. 2023, doi:10.3390/jcm12052036
Lobbes, Marc B I et al.Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers. Breast cancer research and treatment vol. 162,2 (2017): 353-364. doi:10.1007/s10549-017-4117-8
Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2024.AIHW, 2024.
Cserni, Gábor, and Anita Sejben. Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?.Pathology oncology research : POR vol. 26,2 (2020): 665-671. doi:10.1007/s12253-019-00760-8
Pathology Outlines Breast
Breast cancer, Histologic grading
Wang, Y et al. Improved breast cancer histological grading using deep learning. Annals of oncology : official journal of the European Society for Medical Oncology vol. 33,1 (2022): 89-98. doi:10.1016/j.annonc.2021.09.007
Schuh, Fernando et al. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis. Diagnostic pathology vol. 10 93. 10 Jul. 2015, doi:10.1186/s13000-015-0320-2
Schandiz, Hossein et al. Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and potential clinical impact. Breast cancer research and treatment vol. 201,2 (2023): 329-338. doi:10.1007/s10549-023-07016-9
Fung, W Y et al. Safety and efficacy of magnetic seed localisation of non-palpable breast lesions: pilot study in a Chinese population. Hong Kong medical journal = Xianggang yi xue za zhi vol. 26,6 (2020): 500-509. doi:10.12809/hkmj208559
Back